Novel miRNA PC-5P-12969 in Ischemic Stroke

Area of Science:

• Biochemistry
• Neuroscience
• Molecular Biology

Background:

• Circulating microRNAs (miRNAs) are established biomarkers and therapeutic targets for diseases like stroke, Alzheimer's, and cancer.
• Identifying noninvasive, blood-based biomarkers for early detection of ischemic stroke (IS) remains a critical clinical need.
• Previous global miRNA sequencing identified novel miRNAs in IS, including PC-5P-12969, which was exclusively expressed in IS conditions.

Purpose of the Study:

• To investigate the novel microRNA (miRNA) PC-5P-12969 as a potential noninvasive, blood-based early detectable biomarker for ischemic stroke (IS).
• To validate the expression levels of miRNA PC-5P-12969 in both in vitro and in vivo models of stroke.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) assay was employed to measure miRNA PC-5P-12969 expression levels.
• In vitro experiments utilized oxygen and glucose deprivation/reoxygenation (OGD/R)-treated mouse primary hippocampal neuronal cells (HT22).
• In vivo studies involved a photothrombotic stroke model in mice.

Main Results:

• In vitro: A two-fold increase in PC-5P-12969 expression was observed in stroke-induced HT22 cells.
• In vivo: Significantly upregulated levels of PC-5P-12969 were detected in the cerebral cortex of photothrombotic stroke mice at 4 hours and 1 day post-stroke.
• No significant change in PC-5P-12969 expression was found in the cerebellum of stroke or control mice, indicating tissue specificity.

Conclusions:

• The study concludes that miRNA PC-5P-12969 is a potential candidate peripheral biomarker for ischemic stroke (IS).
• MiRNA PC-5P-12969 also represents a potential drug target for IS.
• This research provides the first validation of miRNA PC-5P-12969 as a potential biomarker for IS.